Junya Kanda

Summary

Affiliation: Kyoto University
Country: Japan

Publications

  1. ncbi Reversible cardiomyopathy associated with Multicentric Castleman disease: successful treatment with tocilizumab, an anti-interleukin 6 receptor antibody
    Junya Kanda
    Department of Hematology and Oncology, Kyoto University, Kyoto, Japan
    Int J Hematol 85:207-11. 2007
  2. ncbi Pretransplant serum ferritin and C-reactive protein as predictive factors for early bacterial infection after allogeneic hematopoietic cell transplantation
    J Kanda
    Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Sakyo ku, Kyoto, Japan
    Bone Marrow Transplant 46:208-16. 2011
  3. ncbi Clinical significance of serum hepcidin levels on early infectious complications in allogeneic hematopoietic stem cell transplantation
    Junya Kanda
    Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan
    Biol Blood Marrow Transplant 15:956-62. 2009
  4. ncbi Impact of ABO mismatching on the outcomes of allogeneic related and unrelated blood and marrow stem cell transplantations for hematologic malignancies: IPD-based meta-analysis of cohort studies
    Junya Kanda
    Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, 54 Shogoin Kawahara cho, Sakyo ku, Kyoto, Japan
    Transfusion 49:624-35. 2009
  5. ncbi Impact of graft-versus-host disease on outcomes after allogeneic hematopoietic cell transplantation for adult T-cell leukemia: a retrospective cohort study
    Junya Kanda
    Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, 54 Shogoin Kawaharacho, Sakyo ku, Kyoto, Japan
    Blood 119:2141-8. 2012
  6. ncbi Serum hepcidin level and erythropoietic activity after hematopoietic stem cell transplantation
    Junya Kanda
    Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto 606 8507, Japan
    Haematologica 93:1550-4. 2008
  7. ncbi Clinical significance of subcategory and severity of chronic graft-versus-host disease evaluated by National Institutes of Health consensus criteria
    Takayuki Sato
    Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, 54 Shogoin Kawaharacho, Sakyo ku, Kyoto, 606 8507, Japan
    Int J Hematol 93:532-41. 2011
  8. ncbi Mycophenolate mofetil combined with tacrolimus and minidose methotrexate after unrelated donor bone marrow transplantation with reduced-intensity conditioning
    Chisaki Mizumoto
    Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, 54 Shogoin Kawaharacho, Sakyo ku, Kyoto 606 8507, Japan
    Int J Hematol 89:538-45. 2009
  9. ncbi Oncostatin M and leukemia inhibitory factor increase hepcidin expression in hepatoma cell lines
    Junya Kanda
    Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Sakyo ku, Kyoto, Japan
    Int J Hematol 90:545-52. 2009
  10. ncbi Transplantation of allogeneic hematopoietic stem cells for adult T-cell leukemia: a nationwide retrospective study
    Masakatsu Hishizawa
    Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan
    Blood 116:1369-76. 2010

Detail Information

Publications11

  1. ncbi Reversible cardiomyopathy associated with Multicentric Castleman disease: successful treatment with tocilizumab, an anti-interleukin 6 receptor antibody
    Junya Kanda
    Department of Hematology and Oncology, Kyoto University, Kyoto, Japan
    Int J Hematol 85:207-11. 2007
    ..Administering tocilizumab in cases of MCD with unexplained cardiac dysfunction is worthwhile, because such a complication could be reversible...
  2. ncbi Pretransplant serum ferritin and C-reactive protein as predictive factors for early bacterial infection after allogeneic hematopoietic cell transplantation
    J Kanda
    Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Sakyo ku, Kyoto, Japan
    Bone Marrow Transplant 46:208-16. 2011
    ..It may be prudent to limit antibacterial prophylaxis to patients with predefined risk factors to ensure the safety of HCT with the use of fewer antibiotics...
  3. ncbi Clinical significance of serum hepcidin levels on early infectious complications in allogeneic hematopoietic stem cell transplantation
    Junya Kanda
    Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan
    Biol Blood Marrow Transplant 15:956-62. 2009
    ..Larger prospective studies are, however, warranted to confirm our findings...
  4. ncbi Impact of ABO mismatching on the outcomes of allogeneic related and unrelated blood and marrow stem cell transplantations for hematologic malignancies: IPD-based meta-analysis of cohort studies
    Junya Kanda
    Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, 54 Shogoin Kawahara cho, Sakyo ku, Kyoto, Japan
    Transfusion 49:624-35. 2009
    ..The impact of donor-recipient ABO matching on outcomes after allogeneic stem cell transplantation has been a matter of controversy...
  5. ncbi Impact of graft-versus-host disease on outcomes after allogeneic hematopoietic cell transplantation for adult T-cell leukemia: a retrospective cohort study
    Junya Kanda
    Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, 54 Shogoin Kawaharacho, Sakyo ku, Kyoto, Japan
    Blood 119:2141-8. 2012
    ..Collectively, these results indicate that the development of mild-to-moderate acute GVHD confers a lower risk of disease progression and a beneficial influence on survival of allografted patients with ATL...
  6. ncbi Serum hepcidin level and erythropoietic activity after hematopoietic stem cell transplantation
    Junya Kanda
    Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto 606 8507, Japan
    Haematologica 93:1550-4. 2008
    ..These results indicate the existence of an unknown functional erythropoiesis-associated circulating factor, other than growth differentiation factor-15, that negatively regulates hepcidin production in stem cell transplantation settings...
  7. ncbi Clinical significance of subcategory and severity of chronic graft-versus-host disease evaluated by National Institutes of Health consensus criteria
    Takayuki Sato
    Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, 54 Shogoin Kawaharacho, Sakyo ku, Kyoto, 606 8507, Japan
    Int J Hematol 93:532-41. 2011
    ....
  8. ncbi Mycophenolate mofetil combined with tacrolimus and minidose methotrexate after unrelated donor bone marrow transplantation with reduced-intensity conditioning
    Chisaki Mizumoto
    Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, 54 Shogoin Kawaharacho, Sakyo ku, Kyoto 606 8507, Japan
    Int J Hematol 89:538-45. 2009
    ....
  9. ncbi Oncostatin M and leukemia inhibitory factor increase hepcidin expression in hepatoma cell lines
    Junya Kanda
    Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Sakyo ku, Kyoto, Japan
    Int J Hematol 90:545-52. 2009
    ..Further studies are warranted to evaluate the clinical significance of OSM and LIF in the development of anemia in various inflammatory diseases...
  10. ncbi Transplantation of allogeneic hematopoietic stem cells for adult T-cell leukemia: a nationwide retrospective study
    Masakatsu Hishizawa
    Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan
    Blood 116:1369-76. 2010
    ..In conclusion, allogeneic HSCT using currently available graft source is an effective treatment in selected patients with ATL, although greater effort is warranted to reduce treatment-related mortality...
  11. ncbi Anti-interleukin 6 receptor antibody tocilizumab reduces the level of serum hepcidin in patients with multicentric Castleman's disease
    Hiroshi Kawabata
    Haematologica 92:857-8. 2007
    ..Our results indicate that IL-6-induced hepcidin over-production may be involved in the pathophysiology of microcytic anemia commonly observed in this disease...